Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 725 Shares of Danaher Co. (NYSE:DHR)

Town & Country Bank & Trust CO dba First Bankers Trust CO reduced its position in shares of Danaher Co. (NYSE:DHR) by 5.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 11,669 shares of the conglomerate’s stock after selling 725 shares during the quarter. Danaher comprises 1.2% of Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings, making the stock its 27th biggest position. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Danaher were worth $2,914,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in DHR. Vicus Capital acquired a new position in Danaher in the first quarter valued at approximately $209,000. Investment Research & Advisory Group Inc. acquired a new position in shares of Danaher in the 1st quarter valued at $1,186,000. Griffin Asset Management Inc. boosted its position in shares of Danaher by 0.3% in the 1st quarter. Griffin Asset Management Inc. now owns 50,910 shares of the conglomerate’s stock worth $12,713,000 after purchasing an additional 138 shares during the last quarter. Criterion Capital Advisors LLC grew its stake in shares of Danaher by 2.4% during the first quarter. Criterion Capital Advisors LLC now owns 3,044 shares of the conglomerate’s stock worth $760,000 after purchasing an additional 70 shares during the period. Finally, Independence Bank of Kentucky increased its holdings in Danaher by 72.1% in the first quarter. Independence Bank of Kentucky now owns 6,498 shares of the conglomerate’s stock valued at $1,623,000 after purchasing an additional 2,723 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on DHR. Citigroup upped their price target on Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Bank of America increased their target price on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a report on Wednesday, April 24th. HSBC raised shares of Danaher from a “hold” rating to a “buy” rating and boosted their price target for the company from $250.00 to $280.00 in a report on Wednesday, April 17th. Robert W. Baird raised their price objective on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. Finally, Barclays boosted their target price on Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday, April 24th. Six analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $269.29.

Danaher Stock Down 0.7 %

NYSE:DHR traded down $1.64 on Friday, hitting $249.85. 4,638,276 shares of the company’s stock were exchanged, compared to its average volume of 3,371,169. The firm has a 50-day moving average price of $255.96 and a 200-day moving average price of $246.61. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $269.11. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. The company has a market cap of $185.06 billion, a P/E ratio of 42.35, a price-to-earnings-growth ratio of 3.82 and a beta of 0.85.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. Danaher’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.36 earnings per share. As a group, analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. Danaher’s dividend payout ratio is presently 18.31%.

Insider Buying and Selling

In other news, Director Alan G. Spoon sold 708 shares of Danaher stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the transaction, the director now owns 116,202 shares of the company’s stock, valued at approximately $28,304,483.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, Director Alan G. Spoon sold 708 shares of Danaher stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total transaction of $172,454.64. Following the completion of the transaction, the director now directly owns 116,202 shares in the company, valued at approximately $28,304,483.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction on Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total value of $1,000,040.00. Following the completion of the sale, the senior vice president now owns 29,830 shares in the company, valued at approximately $7,457,798.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 148,783 shares of company stock worth $37,536,717. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.